SUPERNUS PHARMACEUTICA

Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story

01 May 2024 08:00:32 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

24 Apr 2024 16:05:53 By Nasdaq GlobeNewswire

Supernus Provides Regulatory Update for SPN-830

08 Apr 2024 08:00:16 By Nasdaq GlobeNewswire

Supernus to Participate in Two Upcoming Investor Conferences

06 Mar 2024 16:30:50 By Nasdaq GlobeNewswire

Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference

28 Feb 2024 16:30:04 By Nasdaq GlobeNewswire

Supernus Announces Fourth Quarter and Full Year 2023 Financial Results

27 Feb 2024 16:05:33 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024

13 Feb 2024 16:05:20 By Nasdaq GlobeNewswire

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

05 Feb 2024 08:30:39 By Nasdaq GlobeNewswire

Supernus Announces Third Quarter 2023 Financial Results

08 Nov 2023 16:05:44 By Nasdaq GlobeNewswire

Supernus to Participate in the Jefferies London Healthcare Conference

07 Nov 2023 16:30:42 By Nasdaq GlobeNewswire

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

02 Nov 2023 07:00:05 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023

25 Oct 2023 16:15:32 By Nasdaq GlobeNewswire

Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey

16 Oct 2023 17:34:21 By Nasdaq GlobeNewswire

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

09 Oct 2023 16:45:19 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City

27 Sep 2023 16:15:50 By Nasdaq GlobeNewswire

Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms

09 Sep 2023 20:00:30 By Nasdaq GlobeNewswire

Supernus to Participate in the Wells Fargo Healthcare Conference

31 Aug 2023 17:30:19 By Nasdaq GlobeNewswire

Bethany L. Sensenig Joins Supernus’ Board of Directors

21 Aug 2023 09:00:54 By Nasdaq GlobeNewswire

Supernus Announces Second Quarter 2023 Financial Results

08 Aug 2023 16:17:24 By Nasdaq GlobeNewswire

Supernus to Participate in the Jefferies Healthcare Conference

31 May 2023 16:15:48 By Nasdaq GlobeNewswire